|

Prevalence and Clinical Implications of HPV Infection in Male IBD Patients

RECRUITINGSponsored by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Actively Recruiting
SponsorFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Started2023-02-12
Est. completion2026-01-31
Eligibility
Age18 Years – 79 Years
SexMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05911750

Summary

The study aims at describing the prevalence of Human Papillomavirus (HPV) infection in anal and oral samples of men with Inflammatory Bowel Disease (IBD) and detecting risk factors for the infection.

Eligibility

Age: 18 Years – 79 YearsSex: MALEHealthy volunteers accepted
Inclusion Criteria:

* Diagnosed Crohn's disease or ulcerative colitis (at least 3 months before enrollment)
* Male
* Age from 18 to 79 years

Exclusion Criteria:

* Unclassified Inflammatory Bowel Disease
* Diarrhea (\> 3 bowel movements/day) with rectal bleeding at enrollment
* Prior full proctectomy
* Inability to collect the biological samples
* Inability to complete the questionnaire
* Refusal to sign the informed consent

Conditions4

CancerDysplasia AnusHPV InfectionOral Cavity Disease

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.